Dionigi Gianlorenzo, Bacuzzi Alessandro, Lavazza Matteo, Inversini Davide, Boni Luigi, Rausei Stefano, Kim Hoon Yub, Anuwong Angkoon
1st Division of Surgery, Department of Medicine and Surgery, Endocrine Surgery Research Center, University of Insubria, Varese, Italy.
Division of Anesthesia, Ospedale di Circolo, Fondazione Macchi, Varese, Italy.
Updates Surg. 2017 Jun;69(2):225-234. doi: 10.1007/s13304-017-0436-x. Epub 2017 Apr 12.
Transoral endoscopic thyroidectomy vestibular approach (TOETVA) is a feasible novel surgical procedure that does not need visible incisions. We describe our initial experience with TOETVA. We recruited 15 patients who were willing to undergo TOETVA. Inclusion criteria were (a) patients who had a neck ultrasound (US) with a estimated thyroid diameter not larger than 10 cm; (b) US estimated gland volume ≤45 mL; (c) nodule size ≤50 mm; (d) a benign tumor, such as a thyroid cyst, single-nodular goiter, or multinodular goiter; (e) follicular neoplasm; (f) papillary microcarcinoma without evidence of metastasis. The procedure is carried out through a three-port technique placed at the oral vestibule, one 10-mm port for 30° endoscope and two additional 5-mm ports for dissecting and coagulating instruments. CO insufflation pressure is set at 6 mmHg. An anterior cervical subplatysmal space is created from the oral vestibule down to the sternal notch, laterally to the sternocleidomastoid muscle. Thyroidectomy is done fully endoscopically using conventional endoscopic instruments and intraoperative neuromonitoring. There were 34% total thyroidectomies and 66% hemithyroidectomies. All TOETVA procedures were performed successfully with no conversions. The mean operative time was 87.6 (59-118) min for lobectomy and 107.6 (99-135) min for bilateral procedure. We observed one case of transient postoperative hypocalcemia. There was no recurrent laryngeal nerve palsy. The cosmetic result was excellent in all patients. This is the first case series of TOETVA in Italy. TOETVA may provide a method for ideal cosmetic results. The results are encouraging, and we are optimistic about the future expansion of its applicability.
经口内镜甲状腺手术前庭入路(TOETVA)是一种可行的新型手术方法,无需可见切口。我们描述了我们开展TOETVA的初步经验。我们招募了15例愿意接受TOETVA的患者。纳入标准为:(a)颈部超声(US)显示甲状腺直径估计不大于10 cm的患者;(b)US估计腺体体积≤45 mL;(c)结节大小≤50 mm;(d)良性肿瘤,如甲状腺囊肿、单结节性甲状腺肿或多结节性甲状腺肿;(e)滤泡性腺瘤;(f)无转移证据的乳头状微小癌。该手术通过放置在口腔前庭的三通道技术进行,一个10 mm通道用于30°内镜,另外两个5 mm通道用于分离和凝固器械。二氧化碳充气压力设定为6 mmHg。从前庭向下至胸骨切迹、外侧至胸锁乳突肌创建颈前皮下间隙。使用传统的内镜器械和术中神经监测进行全内镜甲状腺切除术。全甲状腺切除术占34%,半甲状腺切除术占66%。所有TOETVA手术均成功完成,无中转。叶切除术的平均手术时间为87.6(59 - 118)分钟,双侧手术为107.6(99 - 135)分钟。我们观察到1例术后短暂性低钙血症病例。无喉返神经麻痹。所有患者的美容效果均极佳。这是意大利首例TOETVA病例系列。TOETVA可能提供一种获得理想美容效果的方法。结果令人鼓舞,我们对其未来适用性的扩展持乐观态度。